CASI PHARMACEUTICALS, INC. Interest Income (Expense), Net
CASI PHARMACEUTICALS, INC. (CASIF) reported Interest Income (Expense), Net of $614.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-28.
Discontinued › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2024-03-28
| Period end | Interest Income (Expense), Net 12 month |
|---|---|
| 2023-12-31 | $614.00K 20-F · filed 2024-03-28 |
| 2022-12-31 | $127.00K 20-F · filed 2024-03-28 |
| 2021-12-31 | $321.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | $866.00K 20-F · filed 2023-04-26 |